Salcedo-Soto Daniela Alejandra, Arvizu-Rivera Rosa I, Garza-Elizondo Angel Kevin, Martinez-Espinosa Hector Alejandro, Gonzalez-Morales Juan Pablo, Skinner-Taylor Cassandra Michele, Serna-Peña Griselda, Villarreal-Alarcon Miguel Angel, Galarza-Delgado Dionicio Angel, Cardenas-de la Garza Jesus Alberto
Rheumatology Department, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
Clin Rheumatol. 2025 May;44(5):1983-1987. doi: 10.1007/s10067-025-07419-7. Epub 2025 Apr 1.
INTRODUCTION/OBJECTIVES: Five autoantibodies are considered specific for dermatomyositis (DM). Among them, anti-small ubiquitin-like modifier (SUMO) activating enzyme (SAE) antibodies are the most infrequent. Information on anti-SAE DM remains limited. We aimed to describe the clinical and serological features of Hispanic patients with anti-SAE DM.
We performed a cross-sectional study at the University Hospital "Dr. José Eleuterio González" in Monterrey, Mexico. The rheumatology laboratory database was searched for all autoimmune inflammatory myopathy immunoblot panels performed from February 2016 to December 2023. Patients with moderate positive or strong positive for anti-SAE, a DM diagnosis by a rheumatologist, and follow-up at our institution were included. Clinical and demographic information was then retrieved from medical records.
A total of 1018 panels were evaluated. Anti-SAE was moderately positive in 4 (0.39%) cases and strongly positive in 10 (0.98%), of which 7 patients met the inclusion criteria. All patients presented skin involvement, including atypical manifestations such as hiker's feet, erythroderma, and panniculitis. Four patients had muscle involvement, of which 2 had elevated creatine kinase levels. Dysphagia was reported in 3 cases. Two patients had interstitial lung disease. No cases of malignancy were identified at follow-up.
Our study highlights the clinical presentation of anti-SAE DM in Hispanic patients, emphasizing the prevalent cutaneous involvement and variable systemic manifestations. Recognizing these features can aid in earlier diagnosis and management. Key Points • Anti-SAE antibody-associated dermatomyositis is uncommon, with 1.4% of evaluated panels showing moderate to strong positivity. • All seven patients with anti-SAE DM in our case series presented with cutaneous involvement. • Atypical skin manifestations were present and included erythroderma, panniculitis, and hiker's feet.
引言/目的:五种自身抗体被认为是皮肌炎(DM)的特异性抗体。其中,抗小泛素样修饰物(SUMO)激活酶(SAE)抗体最为罕见。关于抗SAE DM的信息仍然有限。我们旨在描述西班牙裔抗SAE DM患者的临床和血清学特征。
我们在墨西哥蒙特雷的“何塞·埃莱乌特里奥·冈萨雷斯博士”大学医院进行了一项横断面研究。在风湿病实验室数据库中搜索了2016年2月至2023年12月期间进行的所有自身免疫性炎性肌病免疫印迹检测结果。纳入抗SAE中度阳性或强阳性、经风湿病学家诊断为DM且在我们机构接受随访的患者。然后从病历中获取临床和人口统计学信息。
共评估了1018份检测结果。抗SAE中度阳性4例(0.39%),强阳性10例(0.98%),其中7例患者符合纳入标准。所有患者均有皮肤受累,包括徒步旅行者足、红皮病和脂膜炎等非典型表现。4例患者有肌肉受累,其中2例肌酸激酶水平升高。3例报告有吞咽困难。2例患者有间质性肺病。随访期间未发现恶性肿瘤病例。
我们的研究突出了西班牙裔患者抗SAE DM的临床表现,强调了普遍存在的皮肤受累和多变的全身表现。认识这些特征有助于早期诊断和管理。要点 • 抗SAE抗体相关的皮肌炎并不常见,1.4%的评估检测结果显示中度至强阳性。 • 我们病例系列中的所有7例抗SAE DM患者均有皮肤受累。 • 存在非典型皮肤表现,包括红皮病、脂膜炎和徒步旅行者足。